The store will not work correctly when cookies are disabled.
1-(pyridin-4-yl)imidazo[1,5-a]pyridine-3-carboxamide
ID: ALA3746484
PubChem CID: 127040260
Max Phase: Preclinical
Molecular Formula: C13H10N4O
Molecular Weight: 238.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1nc(-c2ccncc2)c2ccccn12
Standard InChI: InChI=1S/C13H10N4O/c14-12(18)13-16-11(9-4-6-15-7-5-9)10-3-1-2-8-17(10)13/h1-8H,(H2,14,18)
Standard InChI Key: ARICZFDHNYPVCC-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3877 -3.5218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3606 -2.8684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1749 2.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6113 3.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9698 4.5036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8877 5.5424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4470 5.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0885 3.6681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
10 12 2 0
9 10 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
7 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 238.25 | Molecular Weight (Monoisotopic): 238.0855 | AlogP: 1.50 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.28 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.73 | CX Basic pKa: 3.88 | CX LogP: 0.45 | CX LogD: 0.45 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -1.21 |
References
1. Adams M, Kobayashi T, Lawson JD, Saitoh M, Shimokawa K, Bigi SV, Hixon MS, Smith CR, Tatamiya T, Goto M, Russo J, Grimshaw CE, Swann S.. (2016) Fragment-based drug discovery of potent and selective MKK3/6 inhibitors., 26 (3): [PMID:26704264] [10.1016/j.bmcl.2015.11.054] |